Definium Therapeutics, Inc. (DFTX)

SEC filing

Definium Therapeutics, Inc.

DFTX · CIK 1813814

4 · Sep 29, 2026 · Director, Chief Medical Officer Karlin Daniel sold 10.85K Common Shares at $36.57/unit ($396.9K)

Director, Chief Medical Officer Karlin Daniel sold 10.85K Common Shares at $36.57/unit ($396.9K)

Could not load the primary document from EDGAR (SEC rate limit, timeout, or temporary upstream error). Refresh in a minute, or use View on SEC.gov.